"We embed research studies in the comfort and convenience of patient communities. By providing easy access to care, we help patients suffering from debilitating diseases now, while bringing hope for a cure for future generations."

During the past decade, Cognitive Clinical Trials conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 4 clinical trials were completed, i.e. on average, 11.8% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 4 clinical trials were completed. i.e. 17.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cognitive Clinical Trials" #1 sponsor was "ModernaTX, Inc." with 5 trials, followed by "Pfizer" with 5 trials sponsored, "Cassava Sciences, Inc." with 3 trials sponsored, "ACADIA Pharmaceuticals Inc." with 2 trials sponsored and "Altimmune, Inc." with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cognitive Clinical Trials" #1 collaborator was "National Institute on Aging (NIA)" with 3 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator and "Fast-Track Drugs & Biologics, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Cognitive Clinical Trials" are "Migraine" (3 trials), "Respiratory Syncytial Virus" (3 trials), "Alopecia Areata" (2 trials), "Alzheimer Disease" (2 trials) and "Alzheimer's Disease" (2 trials). Many other conditions were trialed in "Cognitive Clinical Trials" in a lesser frequency.

Most popular intervention types in "Cognitive Clinical Trials" are "Drug" (20 trials), "Biological" (11 trials), "Other" (7 trials), "Diagnostic Test" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "mRNA-1345" (3 trials), "ALT-801" (2 trials), "BNT162b2" (2 trials) and "CTP-543" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cognitive Clinical Trials" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Cognitive Clinical Trials". undefined are not yet recruiting, 4 are recruiting, 17 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 9 completed trials in Cognitive Clinical Trials, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cognitive Clinical Trials, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".